News & Updates

An antimicrobial stewardship intervention to reduce the use of piperacillin–tazobactam in children with acute appendicitis has been shown to result in improved clinical outcomes.

The V114-032 trial, presented at ESPID 2026, shows that administering the 15-valent pneumococcal conjugate vaccine (PCV15) reduces the incidence of first vaccine-type acute otitis media (VT-AOM) among healthy children.

Topical application of chlorhexidine 1% proves effective at reducing bacterial load in both mothers and neonates, according to the results of a randomized controlled trial.

Real-life use of letermovir in paediatric recipients of haematopoietic stem cell transplant (HSCT) is generally safe and prevents the development of cytomegalovirus (CMV) disease, as shown in a study presented at ESPID 2026.

Prenatal and early childhood exposure to malaria negatively affect growth outcomes in children, as suggested in a study.

In the treatment of scabies infection in children up to 2 years of age, age-based ivermectin dosing yields high response rates and is well-tolerated, according to the open-label phase 2 ITCHY 2 study.